Early detection of prostate cancer in Syrian men

This study aims to find breast cancer early in Syrian women living in the middle region. It's a program to help detect cancer before symptoms appear, so treatment can start sooner.

This study looks at how well a combination of PSA blood tests and DRE (a finger exam) plus a multi-parameter prostate MRI can help identify clinically significant prostate cancer. If you qualify, your results may help guide how doctors decide next steps for diagnosis.

This trial checks whether an early prostate cancer screening approach can detect clinically significant prostate cancer sooner. It may help participants catch the disease at an earlier stage when treatment can be more effective.

This trial aims to raise awareness and screen for prostate cancer in men aged 50 to 69 across the European Union. You may be able to join if you have never been diagnosed with prostate cancer and haven't had a prostate biopsy or MRI in the last six months.

This study explores what Syrian migrants know and understand about cancer prevention and detection. Researchers want to learn how to better support your community's health through education and awareness.

This study uses a simple blood test to look for microRNA patterns that may help spot prostate cancer earlier and avoid unnecessary biopsies. If you have elevated PSA or suspicious findings, this test might give more information about your risk.